Showing results 153 to 172 of 175
< previous
next >
Issue Date | Title | Author(s) |
2020 | Synergistic Apoptotic Effects of Bortezomib and Methylstat on Multiple Myeloma Cells | Kaci, Fatma Necmiye; Kiraz, Yağmur ; Çekdemir, Demet; Baran, Yusuf |
Jan-2017 | Synthesis, Cytotoxic and Antimicrobial Activities of Novel Cobalt and Zinc Complexes of Benzimidazole Derivatives | Apohan, Elif; Yılmaz, Ülkü; Yılmaz, Özgür; Serindağ, Ayfer; Küçükbay, Hasan; Yeşilada, Özfer; Baran, Yusuf |
Jan-2016 | T Cells in Tumor Microenvironment | Kiraz, Yağmur ; Baran, Yusuf ; Nalbant, Ayten |
2009 | Targeting Ceramide Metabolism Increased Sensitivity of Philadelphia Positif Chronic Megacaryoblastic Leukemia Cells To Dasatinib | Gençer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf |
Mar-2015 | Targeting Foxm1 Transcription Factor in T-Cell Acute Lymphoblastic Leukemia Cell Line | Tüfekçi, Özlem; Kartal Yandım, Melis; Ören, Hale; İrken, Gülersu; Baran, Yusuf |
Oct-2011 | Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation | Baran, Yusuf ; Bielawski, Jacek; Gündüz, Ufuk; Öğretmen, Besim |
2014 | Targeting Sphingosine Kinase-1/Spingosine-1-phosphate Receptor 2 Signalling Pathway To Overcome T315i Mutation in 32dcl3 Cells | Adan Gökbulut, Aysun ; Öğretmen, Besim; Baran, Yusuf |
Oct-2010 | Therapeutic Applications of Bioactive Sphingolipids in Hematological Malignancies | Ekiz, Hüseyin Atakan ; Baran, Yusuf |
May-2014 | Therapeutic Potential of Apigenin, a Plant Flavonoid, for Imatinib-Sensitive and Resistant Chronic Myeloid Leukemia Cells | Solmaz, Soner; Adan Gökbulut, Aysun ; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Boğa, Can; Çakmakoğlu, Bedia; Kozanoğlu, İlknur; Baran, Yusuf |
2015 | Therapeutic Potential of Fisetin and Identification of Its Mechanisms in Action in Chronic Myeloid Leukemia and Acute Promyelocytic Leukemia Cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
2014 | Therapeutic Potential of Fisetin, Vitexin and Hesperetin on Chronic Myeloid Leukemia Cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
2023 | Therapeutic Potential of Luteolin on Cancer | Çetinkaya, Melisa; Baran, Yusuf |
Jan-2013 | Therapeutic Potential of Targeting Ceramide/Glucosylceramide Pathway in Cancer | Kartal Yandım, Melis; Apohan, Elif; Baran, Yusuf |
2010 | Therapeutic Potential of Targeting Sphingolipid Signaling Pathways in Various Types of Cancers | Baran, Yusuf ; Başsoy, Esen Yonca; Çakır, Zeynep; Camgöz, Aylin; Gencer, Emel Başak; Kartal, Melis; Can, Geylani; Ekiz, Hüseyin Atakan ; Güçlüler, Gözde |
2015 | Therapeutic Potentials of Fisetin, Hesperetin and Vitexin on Chronic Myeloid Leukemia and Acute Myeloid Leukemia Cells | Adan Gökbulut, Aysun |
2020 | Therapeutic Potentials of Inhibition of Jumonji C Domain-Containing Demethylases in Acute Myeloid Leukemia | Koca, Duygu; Hastar, Nurcan; Engür, Selin; Kiraz, Yağmur ; Ulu, Gizem Tuğçe ; Çekdemir, Demet; Baran, Yusuf |
2015 | An Update on Molecular Biology and Drug Resistance Mechanisms of Multiple Myeloma | Mutlu, P.; Kiraz, Y. ; Gündüz, U.; Baran, Y. |
Jan-2014 | An Update on Molecular Biology of Thyroid Cancers | Ömür, Özgür; Baran, Yusuf |
Dec-2007 | Upregulation of Multi Drug Resistance Genes in Doxorubicin Resistant Human Acute Myelogeneous Leukemia Cells and Reversal of the Resistance | Baran, Yusuf ; Gür, Bala; Kaya, Pelin; Ural, Ali Uğur; Avcu, Ferit; Gündüz, Ufuk |
2014 | Use of Micrornas in Personalized Medicine | Avci, C.B.; Baran, Y. |